In the future, the medical device sector is still expected to maintain a high boom

In the near future, the medical sector’s prosperity has rebounded significantly.
The medical device sector in the segment has been fully adjusted since July, and has therefore been favored by many institutions.
On the whole, the industry generally believes that the medical device sector is expected to remain in the future.
High boom
.
The industry believes that policies such as the centralized procurement of high-value consumables should be rationally analyzed and cannot be influenced by short-term emotions
.
For example, the recently completed collection of clinical testing reagents in public medical institutions in Anhui Province.
From the results, it is estimated that the profitability of major domestic companies has not been greatly impacted.
At the same time, the abandonment of bids by some foreign-funded companies may also bring opportunities for domestic companies to substitute domestically.

.
In addition, a few days ago, the results of the second batch of national organizations' centralized procurement of high-value medical consumables have been announced.
In this round of artificial joints, a total of 44 companies have been selected, and the prices of artificial joint products to be selected will be reduced by an average of 82%
.
Subsequently, heavyweights such as Mindray Medical, Opcom, Jianfan Biological, and Wantai Biological rebounded strongly
.
Founder Securities believes that the pre-holiday state organization of high-value consumables gathered in the report results announced, the selected product procurement plan will start from March 2022, the overall price reduction rate is relatively mild, the winning rate of this time is more than 70%, of which Group A only needs to be eliminated For 1-2 companies, the final price of the winning bid was relatively moderate compared to the previous price of coronary stents, which reserved some reasonable profit margins for joint companies.
It is expected that domestic companies that have won the bid are expected to increase their domestic market share, and the industry concentration will further increase.
The share of leading domestic companies has increased, which shows that there is no need to be too pessimistic about volume purchases
.
Zhongtai Securities also issued a research report stating that the proportion of imported brands among the three types of hip joints and knee joints in the proposed bid results calculated by the first year's intended purchase volume is in ceramic-ceramic, ceramic-polyethylene, alloy-polyethylene 3 In hip and knee-like joints, the share of imported brands is 49%, 51%, 33%, and 61% respectively.
There is still a large room for import substitution.
Domestic brands are expected to continue to replace imports by virtue of their advantages in quality, price and cost.
Expand market share
.
In addition, Guoyuan Securities believes that it is expected that after 2021, with the pace of medical reform unchanged, the release of new infrastructure construction and new demand is expected to further stimulate the growth of pharmaceuticals.

.
In terms of sectors, the medical device sector has been blessed by the epidemic.
The increase in the purchase of first aid equipment, masks, gloves, and anti-epidemic materials, testing reagents, etc.
, has changed the trend of decline in growth in 2019, and has risen strongly.
It is expected that the overseas epidemic will continue in 2021 and domestic spot investigations.
With the strengthening of new infrastructure at home and abroad, the medical device sector is still expected to maintain a high boom
.
On the whole, many securities institutions are still optimistic about the prosperity of the medical device sector
.
In the long run, with the intensification of aging, people’s health awareness and consumption level upgrades, per capita healthcare consumption expenditure will continue to rise, coupled with the advancement of new infrastructure, as well as hierarchical diagnosis and treatment, mass procurement, DRGs, and medical device registration Under the implementation of policies such as the personnel system and the acceleration of domestic substitution of imports, domestic medical equipment giants have great opportunities for development.
The entire industry will continue to develop at a relatively rapid rate, and the market scale will continue to expand
.
Data show that the size of China's medical device market in 2020 is about 734.
1 billion yuan, an increase of 18.
3% year-on-year
.
It is estimated that in the next 5 years, the average annual compound growth rate of the market size of the medical device field will be about 14%, and it will exceed one trillion by 2023
.